BRCA1 and breast carcinoma: We have tested PREDICT model in retrospective follow-up data from BRCA1/2 carrier patients from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) and the Breast Cancer Association Consortium (BCAC).